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a b s t r a c t
Breast cancer is the second most common cancer after lung cancer. So far, in clinical practice, most cancer
parameters originating from histopathology rely on the visualization by a pathologist of microscopic
structures observed in stained tissue sections, including immunohistochemistry markers. Fourier
transform infrared spectroscopy (FTIR) spectroscopy provides a biochemical fingerprint of a biopsy
sample and, together with advanced data analysis techniques, can accurately classify cell types. Yet, one
of the challenges when dealing with FTIR imaging is the slow recording of the data. One cm2 tissue
section requires several hours of image recording. We show in the present paper that 2D covariance
analysis singles out only a few wavenumbers where both variance and covariance are large. Simple
models could be built using 4 wavenumbers to identify the 4 main cell types present in breast cancer
tissue sections. Decision trees provide particularly simple models to reach discrimination between the
4 cell types. The robustness of these simple decision-tree models were challenged with FTIR spectral data
obtained using different recording conditions. One test set was recorded by transflection on tissue
sections in the presence of paraffin while the training set was obtained on dewaxed tissue sections by
transmission. Furthermore, the test set was collected with a different brand of FTIR microscope and a
different pixel size. Despite the different recording conditions, separating extracellular matrix (ECM)
from carcinoma spectra was 100% successful, underlying the robustness of this univariate model and the
utility of covariance analysis for revealing efficient wavenumbers. We suggest that 2D covariance maps
using the full spectral range could be most useful to select the interesting wavenumbers and achieve very
fast data acquisition on quantum cascade laser infrared imaging microscopes.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Breast cancer is the second most common cancer after lung
cancer. Its incidence is still growing (by 0.4% during the last 5 years)
in the US [1] but increased by 40% among the Gulf Cooperation
Council Countries women during the last 12-year period analyzed
[2]. The precise identification of tumor molecular parameters and
their integration in cancer management is crucial for improving
cancer therapy as well as for moving towards individual therapy. So
far, in clinical practice, most cancer parameters originating from
histopathology rely on the visualization by a pathologist of micro-
scopic structures observed in stained tissue sections, including
immunohistochemistry (IHC) markers (HR, HER2, Ki-67and/or
basal cell markers such as CK5/6 and EGFR) that are largely used
in the clinic [4]. In practice, the classifications obtained using these
markers help, statistically speaking, define a therapy and provide a
prognosis. At individual level however, they are largely insufficient
to deal with individual cases. The origin of this failure can be largely
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found in the huge heterogeneity of the tumors. Tumor cells mutate
at a high rate and a single tumor may contain many different clones
[5,6] with different properties which are difficult to identify. A
further complexity arises from the interplay between tumor cells
and the microenvironment. Finally, the distinct molecular charac-
teristics of the tumors that can have profound implications on
clinical behaviors and long-term patient outcomes [7,8] are not
fully considered. The result is that most of these parameters, e.g. the
histological grade, are associated with inter- and intra-observer
discrepancies, in addition to suffering from a quantification
problem.
Addressing the heterogeneity of the tumor at microscopic level
is not a simple problem. It requires both in depth analysis of the
cells contained in the tissue section and a microscopic approach
which can provide such an analysis at the cellular level. As far as in-
depth analysis is concerned, the development of microarray-based
gene expression profiling technologies has helped explain some of
this heterogeneity, in particular by sub-classifying human breast
carcinomas and establishing molecular-based prognostic and pre-
dictive signatures [4,9e12]. The complexity and cost of gene
expression profiling limit its use as a routine hospital diagnostic
tool. Furthermore, it cannot be applied systematically at the cellular
level. This results in an incomplete picture of the heterogeneity of
the tumor [13]. Reflecting this cellular heterogeneity therefore re-
quires new approaches.
Some emerging imaging technologies (e.g., mass spectrometry-
based “omics” techniques [14,15]) reveal many more biomarkers
than immunohistochemical approaches [16,17]. They are promising
but not yet robust enough to ensure high-throughput analysis of
histological sections in routine pathology. Presently, vibrational
spectral histopathology (FTIR or Raman imaging) represents the
only method that provides simultaneously, for each pixel of the
acquired image, hundreds of robust markers related to the molec-
ular content of the cells [18,19]. Fourier transform infrared (FTIR)
spectroscopy has recently shown great potential for disease diag-
nosis in the field of breast cancer [20e22]. These techniques can
provide a biochemical fingerprint of a biopsy sample and, together
with advanced data analysis techniques, can accurately classify cell
types. Each cellular component has a characteristic set of vibra-
tional transitions resulting in a unique spectrum. It is now
considered that vibrational spectroscopies provide as much infor-
mation as DNA microarrays as far as diagnostic purposes are con-
cerned. Importantly, they can also identify all molecule types as
well as details of their chemical structure. For instance the length of
lipid acyl chains, the degree of unsaturation of lipids [23], the lipid/
protein ratio, DNA condensation state [24] and many other pa-
rameters can be obtained from vibrational spectra. In particular,
information not only on the chemical nature of cell molecules but
also their conformations can be obtained. They are, in particular
very sensitive to protein secondary structure [25,26]. Altogether,
the various contributions to the spectrum form a signature of the
molecular composition of the cell that is unique. Multivariate
analysis of spectral data results in remarkably sensitive segmen-
tation of the cells present in a tissue section [27]. Recent progresses
in FTIR imaging makes it possible to record images of tissue sec-
tions with a spatial resolution close to the cell size. Yet, one of the
challenges when dealing with FTIR imaging is the still slow
recording and handling of data [19]. When recording FTIR images
with a pixel size of 2.7 2.7 mm2 as described in this work, a 1 cm2
image contains 13.4 million spectra which are recorded between
4000 and 900 cm1 for most Focal Plane Array (FPA) detectors, each
one containing about 1500 data points. Recording such an image
takes several hours, limiting the application of the technology. Yet,
not all of this data is useful for identifying cell types. Recording FTIR
images with quantum cascade lasers [28e30] and their analysis
would be considerably faster if the useful spectral region were
known. For this purpose, analysis of variance is a key issue. Spectral
regions with no variance throughout the dataset are obviously of no
interest and the co-varying wavenumbers could be reduced to a
limited number of wavenumbers as they describe the same varia-
tions among cell types.
We propose in the present paper to use 2D correlation analysis
to simplify the dataset and possibly identify the few wavenumbers
that are of interest for the identification of the various cell types
such as carcinoma cells, erythrocytes, lymphocytes and the extra-
cellular matrix (ECM). In the near future, this first approach will
have to be followed by an attempt to identify various types of tumor
clones in a tissue section.
2. Materials and methods
Spectra of breast carcinoma cells, erythrocytes, lymphocytes
and extracellular matrix were obtained from a databasemaintained
in-house. A full description of the samples can be found in Benard
et al. [27]. Briefly formalin-fixed paraffin-embedded (FFPE) breast
cancer tissues from 66 patients were provided from the tumor
tissue bank of the Jules Bordet Institute (Brussels, Belgium). To
enrich the database on the immune and stromal responses, seven
lymph nodes and three tonsils as well as seven scars from mas-
tectomy biopsied tissue samples were also included. As described
in the previous paper [27], more than 13,000 representative spectra
were extracted from the images under the supervision of a trained
pathologist.
As described previously [27], the FTIR data were collected using
a Hyperion 3000 FTIR imaging system (Bruker Optics, Ettlingen,
Germany), equipped with a 64*64 Mercury Cadmium Telluride
(MCT) Focal Plane Array (FPA) detector. Data were collected in
transmissionmode from sample regions of 184*184 mm2. Each pixel
corresponds to an area of 2.7*2.7 mm2. One FTIR image (unit image)
resulted in 4096 spectra, each one being the average of 256 scans
recorded in a spectral range from 3900 to 800 cm1. The spectral
resolutionwas set to 8 cm1 and data points encoded every 1 cm1.
Spectral processing was performed as described [27]. Briefly, water
vapor contribution was subtracted with 1956-1935 cm1 as the
reference peak. In order to eliminate any intensity variation caused
by changes in the thickness of the tissue section or quantity of
cellular material, the spectra were normalized for equal area be-
tween 1725 and 1481 cm1. An 11-point baseline correction was
subtracted. For this purpose, straight lines were interpolated be-
tween the spectral points at 3620, 2995, 2800, 2395, 2247, 1765,
1724, 1480, 1355, 1144 and 950 cm1 and subtracted from each
spectrum. Pre-processed spectra were retained for further analyses
when the Signal-to-Noise ratio (S/N) was greater than 300:1 for the
Amide I and II region (from 1750 to 1480 cm1). This ratio was
calculated considering Signal as the maximum absorbance within
1750-1480 cm1 spectra range and Noise as the standard deviation
within 2200-2100 cm1 range.
For validation, a new set of samples was obtained from the
Cancer Registry Office in Al-Amal Hospital, Hamad Medical Cor-
poration (HMC), Doha, Qatar, cut as 5 mm thick sections and imaged
without removing paraffin. FTIR data were collected using an Agi-
lent 128 128 focal plane array (FPA) mid-IR imager. No binning
was applied. Spectra were collected between 3950 and 900 cm1 at
a nominal resolution of 8 cm1 and encoded every 2 cm1. Each
spectrumwas the mean of 64 scans. The microscope was equipped
with a liquid nitrogen cooled 128 128 Mercury Cadmium Tellu-
ride (MCT) Focal Plane Array (FPA) detector and a 15 objective
(NA¼ 0.62). Each pixel corresponds to an area 5.5 5.5 mm2. The
data were collected in transflexion mode from sample regions of
700 700 mm2. One FTIR image (unit image) resulted in 16,384
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spectra. To cover larger sample areas an automatic tiling combined
several FTIR unit images in order to obtain one large mosaic FTIR
image. This project was approved by the ethics committee.
Two-dimensional (2D) covariance spectra were calculated as
described by Noda [31e33]. Computation was carried out using the
Hilbert transform, as described [34,35]. Decision trees were
computed with Matlab. For building the decision trees, an optimal
solution was searched to divide the data set into predefined groups
on the basis of a threshold absorbance value at a limited number of
wavenumbers. To predict a response, the decisions described in the
tree from the root (beginning) node down to a leaf node were
followed. The leaf node contains the response. For validation, the
sum of the misclassification was obtained for each node. In
“resubstitution” evaluation of the classification tree, the whole data
set was used for design and for testing, resulting in an optimistic
estimate of the error. In “cross-validation” validation, a 10-fold
cross-validation was used to compute the cost at each node. The
sample was first partitioned into 10 subsamples, chosen randomly
but with roughly equal size and the same class proportions. For
each subsample, a tree is built and tested on the remaining data.
The information from all subsamples was used to compute the cost
for the whole sample.
Correction of the IR spectra for water vapor and atmospheric
CO2 contribution, baseline subtraction, normalization, application
of quality filters, 2D covariance maps, principal component analysis
(PCA) and decision tree analyses were carried out by Kinetics, a
custom-made program running under Matlab (Mathworks, Inc.).
3. Results
A random selection of 100 spectra belonging to 10 different
patients for each cell type, breast carcinoma, erythrocytes,
lymphocyte and extracellular matrix (ECM), were used to analyze
the variance present throughout the dataset. Fig. 1 provides an
overview of the spectra used.
Overall, there is a level of variance within each group as well as
between groups which can be observed with the naked eye. There
are also between-group differences that can be observed, for
instance the weaker absorbance of the extracellular matrix (ECM)
spectra in the 1070 cm1 region.
3.1. 2D covariance analysis
Fig. 2 reports a 2D covariance analysis performed on the 400
spectra presented in Fig. 1. Even though the terminology “2D cor-
relation” is usually used in the literature, we prefer here to use “2D
covariance” as spectra have not been normalized by the standard
deviation, which would result in a true correlation coefficient map.
It can be observed in Fig. 2 that maxima and minima in the
synchronous covariance map appear at discrete locations. The
dotted line in Fig. 2 placed at 1670 cm1 crosses 10 extrema of the
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Fig. 1. Overlay of 100 spectra of lymphocytes (green), breast carcinoma cells (blue),
erythrocytes (red) and extracellular matrix (ECM) (magenta). Spectra have been pro-
cessed and normalized as described in Methods. For the sake of clarity, spectra of each
cell type have been offset along the absorbance axis.(For interpretation of the refer-
ences to colour in this figure legend, the reader is referred to the web version of this
article.)
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Fig. 2. Synchronous covariance map for the 400 spectra presented in Fig. 1. The red dotted line placed at 1670 cm1 crosses 10 extrema reported in the right panel. The signs in the
right panel indicate whether the covariance is positive or negative. The vertical dotted lines indicate the same wavenumber on the X axis.
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covariance map that are reported in the right panel with a sign
indicating whether the covariance is positive or negative. All co-
variances found on the diagonal (actually the variances) are obvi-
ously positive. It can be observed that thewavenumbers reported in
the right panel of Fig. 2 summarize quite well all the wavenumbers
presenting extrema in the map. For that reason, it was of interest to
examine whether these wavenumbers could be of any use to
discriminate the different cell types.
3.2. Principal component analysis (PCA)
PCA is the method of choice to extract co-varying spectral fea-
tures. It is therefore of interest to compare the synchronous
covariance data with the principal components. Fig. 3 reports the
result of a principal component analysis performed between 1800
and 1000 cm1 on the spectra presented in Fig. 1. It can be observed
that the score plot of the 400 spectra separates well the 4 cell types
as shown in Fig. 3A. PC3 further separates lymphocytes from the
other classes but further PCs do not contribute significantly to
separation (not shown). The wavenumbers identified on Fig. 2 are
indicated by the red dotted lines in Fig. 3. There is in general a good
match between the synchronous correlation data and PCA, as ex-
pected since PCs are the eigen vectors of the covariance matrix.
It can be concluded that PCA identifies the same wavenumbers.
One advantage of PCA is that it identifies the wavenumbers that co-
vary (all positive and negative peaks present on the same PC) and
the score plot already suggests which PCs are related to the ex-
pected discrimination. However, the synchronous map (Fig. 2)
might be simpler to read.
3.3. Discrimination based on absorbance at a few wavenumbers
In order to examine the absorbance at each selected wave-
number, the 400 spectra have been represented as images. For
instance, Fig. 4 reports the absorbance of the 400 spectra at
1065 cm1, each absorbance value being represented by a colored
pixel of an image. It can be observed that, on the one hand,
erythrocytes and ECM form a group and, on the other hand, lym-
phocytes and carcinoma form another quite distinct group. It
therefore appears that the absorbance at 1065 cm1 could be very
useful to discriminate between these two groups. This might be
rationalized considering the absence of nucleic acid in erythrocytes
and the small amounts of nucleic acids in the ECM associated with
the presence of only a few scattered cells (essentially fibroblasts).
The same process was repeated for the 10 wavenumbers identified
by 2D covariance analysis. Results are reported in Fig. 5.
It can now be observed that some wavenumbers almost
uniquely identify some specific cell types. In particular, the ECM
appears with a much higher absorbance than the other cell types at
1203, 1235, 1340 and 1560 cm1. The erythrocytes are uniquely
identified at 1305 cm1 and the lymphocytes at 1620 cm1, albeit
with a larger degree of confusion.
3.4. Discrimination based on absorbance at a few wavenumbers
In view of the previous observations, we decided to build a
decision tree using the absorbances at these 10 wavenumbers to
create a model able to discriminate the 4 cell types. Fig. 6 shows
such a decision tree.
Interestingly, Fig. 6 reveals that knowledge of the absorbance at
only 3 wavenumbers is sufficient to achieve a good classification.
3.5. Discrimination based on absorbance ratios
A potentially more robust approach consists of using ratios of
absorbances rather than absorbances. Ratios of absorbances do not
depend on scaling, which represents a significant advantage. Yet,
one of the problems is the selection of the absorbance ratios that
are most discriminant. Considering for instance spectra with
n¼ 500 data points, the number of possible combinations is n.(n-
1)/2 i.e. 124,750 absorbance ratio values instead of 500 in the
original spectrum. Using the 10 wavenumbers identified by 2D
covariance analysis (Fig. 2), this number reduces to 45 possible
combinations. We rebuilt for each sample “spectra” composed of
these 45 absorbance ratios and constructed a decision tree similar
to the one shown in Fig. 6. Fig. 7 shows the decision tree obtained
using absorbance ratios.
In the training set used, >98% correct classificationwas achieved
for all cell types.
3.6. Validations
A series of 1000 spectra for each cell type were randomly
selected among samples which were not included in the previous
analysis. Using the rules depicted in the decision tree presented in
Fig. 7 and 96.9% of the ECM samples were correctly identified. The
figures for correctly identified cell types are 95.1% for carcinoma,
95.1% for erythrocytes and 68% for lymphocytes.
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Fig. 3. Principal component analysis of the spectra reported in Fig. 1. A. score plot for
100 spectra of lymphocytes (green), breast carcinoma cells (blue), erythrocytes (red)
and extracellular matrix (ECM) (magenta). The fraction of the variance explained by
PC1 and PC2 is indicated on the axes, B. the first two principal components. The ver-
tical dotted lines identify the wavenumbers indicated in Fig. 2.(For interpretation of
the references to colour in this figure legend, the reader is referred to the web version
of this article.)
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For the sake of generality, we also tested the model on a
completely different dataset. For this validation, tissue sections
from the Cancer Registry Office in Al-Amal Hospital, Hamad Med-
ical Corporation (HMC), Doha, Qatar, were cut into 5 mm thick
sections and FTIR images were recorded with an Agilent 128 128
focal plane array (FPA) mid-IR imager. These tissue sections dis-
played both carcinoma areas and ECM areas. Here, contrary to the
previous samples, paraffin was not removed and spectra were
recorded by transflection rather than by transmission resulting in
slightly different spectra [36,37]. The advantages of not removing
paraffin are: 1) it speeds up the imaging process, 2) it alleviates the
scattering problem related to refractive index variations in the
sample as it preserves a rather continuous value of the refractive
index throughout the image [38] and [3]) it stabilizes the sample by
maintaining it in a paraffin environment rather than exposed to air
and humidity. Furthermore, paraffin contributions (C-H stretching,
3000-2800 cm1, and C-H bending, 1500-1350 cm1) can be dis-
carded from further analyses. Specific algorithms [39e41] have
been designed for subtracting paraffin. In our study, contribution of
paraffin was merely subtracted to obtain a zero area between 1490
and 1428 cm1, and this region (1500-1400 cm1) was not used for
further analyses. In the example shown in Fig. 8, 400 spectra from
carcinoma areas and 400 spectra from ECM areas were compared.
As the region between 1500 and 1400 cm1 was not used because
on uncertainty on the quality of paraffin contribution subtraction,
we used the absorbance ratio A1670/A1235. The decision tree re-
ported in Fig. 7 indicated that this ratio should separate carcinoma
cells from lymphocytes. Fig. 8 shows perfect discrimination ob-
tained on this completely different sample set, underlying the
robustness of the approach. It can be observed that not a single blue
pixel can be found in the carcinoma area of the image and not a
single yellow-red pixel can be found in the ECM area of the image.
4. Discussion
Our study showed that 2D covariance analysis singles out only a
few wavenumbers where both variance and covariance are large.
From the 10 selectedwavenumbers, simplemodels could be built to
identify the main cell types present in breast cancer tissue sections.
Three wavenumbers were necessary to identify correctly 100% of
the cell species present in the training test using absorbance values
but 4 wavenumbers were necessary when using absorbance ratios.
In fact, in the former case, the normalization step applied would
require at least one additional wavenumber. It must be noted here
that the spectral barcodes proposed by Nallala et al. [42] is another
approach that identifies important wavenumbers but it is based on
a supervised selection of discriminant spectral ranges characterized
by a statistical test and a P-value.
The decision trees provide particularly simple models to reach
discrimination between the 4 cell types. It could be expected that a
model based on only 4 wavenumbers is less robust than a fully
multivariate model. We tested this robustness on a simple model
containing only carcinoma and ECM areas. Yet, the challenge was
that these samples were obtained in completely different condi-
tions. The sample was recorded by transflection on tissue sections
in the presence of paraffin while the training set was obtained on
dewaxed tissue sections by transmission. Furthermore, the test set
was collected with a different brand of FTIR microscope and a
different pixel size. Yet, separating ECM from carcinoma spectra
was 100% successful as shown in Fig. 8, underlying the robustness
of this univariate model and the utility of covariance analysis for
selectingwavenumbers. It must be stressed that in the general case,
the contribution of paraffin to the spectra must be carefully
considered and approximate subtraction could lead to artifacts if
the selected wavenumbers were in a region of strong paraffin
absorbance, essentially the d(CH2) band around 1455 cm1.
FTIR images of tissues sections obtained with a FPA contain
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Fig. 4. Absorbance at 1065 cm1 (A1065) of the 400 spectra reported in Fig. 1. Each spectrum is represented as a square, there are 20 20 such squares. The color reports the
absorbance according to the color bar on the right hand side of the figure. From the bottom, the first 5 rows report the absorbance of lymphocyte spectra. The next group of 5 rows
are A1065 carcinoma cells, then of erythrocyte spectra and finally ECM spectra at the top.(For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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millions of spectra obtained after several hours of recording, which
is too slow for clinical applications. Recent studies on prostate
cancer indicate that once spectral biomarkers have been pre-
determined, good diagnostics can be obtained based on a limited
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Fig. 5. Absorbance at the wavenumber indicated on top of each image for the 400 spectra reported in Fig. 1. Each spectrum is represented as a square, there are 20 20 such squares
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Fig. 6. Top: decision tree built on the basis of the absorbances at the 10 wavenumbers
identified by 2D covariance analysis (Fig. 2). Bottom: evolution of the residual variance
as a function of the number of terminal nodes obtained by re-substitution (blue line)
and cross-validation (red line), see Methods.(For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 7. Top: decision tree built on the basis of the absorbance ratios using the 10
wavenumbers identified by 2D covariance analysis (Fig. 2). The 4 wavenumbers used
are circled in red on the right hand side of the figure. Bottom: evolution of the residual
variance as a function of the number of terminal nodes obtained by re-substitution
(blue line) and cross-validation (red line), see Methods.(For interpretation of the ref-
erences to colour in this figure legend, the reader is referred to the web version of this
article.)
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number of discrete spectral features [43]. With the advent of
broadly tunable quantum cascade lasers (QCL), a new type of FTIR
imaging is emerging, resulting in fast discrete frequency IR (DF-IR)
spectral imaging [44]. For instance 12 million sparse-frequency
spectra (ca 2 cm2 tissue sample) could be recorded in ca 15min
on a liver biopsy [45]. As reported by Kimber and Kazarian [46], less
than 1min is necessary to record 230,000 spectra counting 9
discrete frequencies necessary to achieve good classification of
serum samples [47]. In this context, 2D covariance analysis using
the full spectral range could be most useful to select the interesting
wavenumbers and achieve very fast data acquisition on QCL-based
systems.
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